|
COX18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
2.19499999999373E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.748000E-01 |
| Stage1-vs-Stage3 |
1.657630E-03 |
| Stage1-vs-Stage4 |
1.344340E-02 |
| Stage2-vs-Stage3 |
1.237880E-02 |
| Stage2-vs-Stage4 |
2.368300E-02 |
| Stage3-vs-Stage4 |
8.436400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.66740004820576E-10 |
| Normal-vs-Asian |
4.512000E-01 |
| Caucasian-vs-AfricanAmerican |
2.331000E-01 |
| Caucasian-vs-Asian |
2.598200E-01 |
| AfricanAmerican-vs-Asian |
3.871000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.969500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.55250273642582E-11 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
6.30830054859643E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.665600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.163400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.648600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.551400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.038800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.251200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.26339999995118E-06 |
| Normal-vs-Grade 2 |
1.11022302462516E-16 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
7.792400E-01 |
| Grade 1-vs-Grade 3 |
7.742600E-01 |
| Grade 1-vs-Grade 4 |
2.867800E-01 |
| Grade 2-vs-Grade 3 |
1.939390E-01 |
| Grade 2-vs-Grade 4 |
1.184370E-02 |
| Grade 3-vs-Grade 4 |
1.409250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62458935193399E-12 |
| Normal-vs-ccB subtype |
1.93844940099552E-12 |
| ccA subtype-vs-ccB subtype |
3.298400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62458935193399E-12 |
| Normal-vs-N1 |
2.75080000000649E-06 |
| N0-vs-N1 |
8.449200E-01 |
|
|
